Related references
Note: Only part of the references are listed.WNT/β-catenin pathway activation in Myc immortalised cerebellar progenitor cells inhibits neuronal differentiation and generates tumours resembling medulloblastoma
H. A. Rogers et al.
BRITISH JOURNAL OF CANCER (2012)
Histone deacetylase inhibitor-mediated sensitization to TRAIL-induced apoptosis in childhood malignancies is not associated with upregulation of TRAIL receptor expression, but with potentiated caspase-8 activation
Juergen Sonnemann et al.
CANCER BIOLOGY & THERAPY (2012)
Sorafenib and HDAC inhibitors synergize to kill CNS tumor cells
Yong Tang et al.
CANCER BIOLOGY & THERAPY (2012)
Spheres without Influence: Dissociating In Vitro Self-Renewal from Tumorigenic Potential in Glioma
Tracy-Ann Read et al.
CANCER CELL (2012)
Self-Renewal Does Not Predict Tumor Growth Potential in Mouse Models of High-Grade Glioma
Lindy E. Barrett et al.
CANCER CELL (2012)
OTX2 Represses Myogenic and Neuronal Differentiation in Medulloblastoma Cells
Ren-Yuan Bai et al.
CANCER RESEARCH (2012)
Expression analysis of stem cell-related genes reveal OCT4 as a predictor of poor clinical outcome in medulloblastoma
Carolina Oliveira Rodini et al.
JOURNAL OF NEURO-ONCOLOGY (2012)
Dissecting the genomic complexity underlying medulloblastoma
David T. W. Jones et al.
NATURE (2012)
Medulloblastomics: the end of the beginning
Paul A. Northcott et al.
NATURE REVIEWS CANCER (2012)
A novel human high-risk ependymoma stem cell model reveals the differentiation-inducing potential of the histone deacetylase inhibitor Vorinostat
Till Milde et al.
ACTA NEUROPATHOLOGICA (2011)
Eyes Wide Open: A Critical Review of Sphere-Formation as an Assay for Stem Cells
Erika Pastrana et al.
CELL STEM CELL (2011)
The histone deacetylase inhibitor sodium butyrate in combination with brain-derived neurotrophic factor reduces the viability of DAOY human medulloblastoma cells
Carolina Noer et al.
CHILDS NERVOUS SYSTEM (2011)
Histone deacetylase inhibitors prime medulloblastoma cells for chemotherapy-induced apoptosis by enhancing p53-dependent Bax activation
S. Haecker et al.
ONCOGENE (2011)
Identification and Characterization of KCASH2 and KCASH3, 2 Novel Cullin3 Adaptors Suppressing Histone Deacetylase and Hedgehog Activity in Medulloblastoma
Enrico De Smaele et al.
NEOPLASIA (2011)
Expression of the AMPA receptor subunits GluR1 and GluR2 is associated with granule cell maturation in the dentate gyrus
Hideo Hagihara et al.
FRONTIERS IN NEUROSCIENCE (2011)
Turning off the switch in medulloblastoma The inhibitory acetylation of an oncogene
Gianluca Canettieri et al.
CELL CYCLE (2010)
Recent Therapeutic Advances for Treating Medulloblastoma: Focus on New Molecular Targets
A. L. Schmidt et al.
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2010)
Phase I study of temozolomide combined with oral etoposide in children with recurrent or progressive medulloblastoma
Antonio Ruggiero et al.
EUROPEAN JOURNAL OF CANCER (2010)
BDNF and PDE4, but not the GRPR, Regulate Viability of Human Medulloblastoma Cells
Anna Laura Schmidt et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2010)
Histone deacetylase and Cullin3-RENKCTD11 ubiquitin ligase interplay regulates Hedgehog signalling through Gli acetylation
Gianluca Canettieri et al.
NATURE CELL BIOLOGY (2010)
Cerebellar stem cells act as medulloblastoma-initiating cells in a mouse model and a neural stem cell signature characterizes a subset of human medulloblastomas
R. Sutter et al.
ONCOGENE (2010)
Isolation, Enrichment, and Maintenance of Medulloblastoma Stem Cells
Xi Huang et al.
Jove-Journal of Visualized Experiments (2010)
Sodium butyrate enhances the cytotoxic effect of antineoplastic drugs in human lymphoblastic T-cells
M. P. dos Santos et al.
LEUKEMIA RESEARCH (2009)
Multiple recurrent genetic events converge on control of histone lysine methylation in medulloblastoma
Paul A. Northcott et al.
NATURE GENETICS (2009)
GSK3β Regulates Differentiation and Growth Arrest in Glioblastoma
Serdar Korur et al.
PLOS ONE (2009)
Brain cancer propagating cells: biology, genetics and targeted therapies
Costas G. Hadjipanayis et al.
TRENDS IN MOLECULAR MEDICINE (2009)
Cancer Stem Cells and the Biology of Brain Tumors
Debora Gazzana Flores et al.
CURRENT STEM CELL RESEARCH & THERAPY (2009)
Musashi I modulates cell proliferation genes in the medulloblastoma cell line Daoy
Patricia C. Sanchez-Diaz et al.
BMC CANCER (2008)
Medulloblastoma: From molecular pathology to therapy
Alessandra Rossi et al.
CLINICAL CANCER RESEARCH (2008)
Tumor environment dictates medulloblastoma cancer stem cell expression and invasive phenotype
Borhane Annabi et al.
MOLECULAR CANCER RESEARCH (2008)
Medulloblastoma in childhood: new biological advances
John R. Crawford et al.
LANCET NEUROLOGY (2007)
Medulloblastoma: tumorigenesis, current clinical paradigm, and efforts to improve risk stratification
William R. Polkinghorn et al.
NATURE CLINICAL PRACTICE ONCOLOGY (2007)
Inhibitors of histone deacetylases as potential therapeutic tools for high-risk embryonal tumors of the nervous system of childhood
Sarah E. Furchert et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Chromatin modifications and their function
Tony Kouzarides
CELL (2007)
Suppressors of Hedgehog signaling - Linking aberrant development of neural progenitors and tumorigenesis
Lucia Di Marcotullio et al.
MOLECULAR NEUROBIOLOGY (2006)
Evaluation of MTT assay for measurement of emodin-induced cytotoxicity
Xiangfei Wang et al.
ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES (2006)
Clonogenic assay of cells in vitro
Nicolaas A. P. Franken et al.
NATURE PROTOCOLS (2006)
Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer
S Minucci et al.
NATURE REVIEWS CANCER (2006)
Anticancer activities of histone deacetylase inhibitors
Jessica E. Bolden et al.
NATURE REVIEWS DRUG DISCOVERY (2006)
Valproic acid induces growth arrest, apoptosis, and senescence in medulloblastomas by increasing histone hyperacetylation and regulating expression of p21Cip1, CDK4, and CMYC
XN Li et al.
MOLECULAR CANCER THERAPEUTICS (2005)
Multiagent chemotherapy and deferred radiotherapy in infants with malignant brain tumors: A report from the children's cancer group
JR Geyer et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Epigenetic and chromatin modifiers as targeted therapy of hematologic malignancies
KN Bhalla
JOURNAL OF CLINICAL ONCOLOGY (2005)
Phenylbutyrate and phenylacetate induce differentiation and inhibit proliferation of human medulloblastoma cells
XN Li et al.
CLINICAL CANCER RESEARCH (2004)
RENKCTD11 is a suppressor of Hedgehog signaling and is deleted in human medulloblastoma
L Di Marcotullio et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Histone deacetylase interacts directly with DNA topoisomerase II
SC Tsai et al.
NATURE GENETICS (2000)
Share Paper
